BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He Y, Ren XJ, Hu BJ, Lam WC, Li XR. A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema. BMC Ophthalmol. 2018;18:121. [PMID: 29784048 DOI: 10.1186/s12886-018-0779-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Lin Y, Ren X, Chen D. Steroid Treatment in Macular Edema: A Bibliometric Study and Visualization Analysis. Front Pharmacol 2022;13:824790. [PMID: 35273502 DOI: 10.3389/fphar.2022.824790] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Deutsche Ophthalmologische Gesellschaft (DOG), Retinologische Gesellschaft e. V. (RG), Berufsverband der Augenärzte Deutschlands e. V. (BVA). Stellungnahme der DOG, der RG und des BVA zur Therapie des diabetischen Makulaödems: Stand August 2019. Ophthalmologe 2020;117:218-47. [DOI: 10.1007/s00347-019-01015-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
3 Cakir A, Erden B, Bolukbasi S, Aydin A, Yurttaser Ocak S, Maden G, Elcioglu MN. Comparison of the effect of ranibizumab and dexamethasone implant in diabetic macular edema with concurrent epiretinal membrane. J Fr Ophtalmol 2019;42:683-9. [PMID: 31088741 DOI: 10.1016/j.jfo.2019.02.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Ward R, Ali Z, Slater K, Reynolds AL, Jensen LD, Kennedy BN. Pharmacological restoration of visual function in a zebrafish model of von-Hippel Lindau disease. Dev Biol 2020;457:226-34. [PMID: 30825427 DOI: 10.1016/j.ydbio.2019.02.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
5 Wang JK, Huang TL, Chang PY, Ho WT, Hsu YR, Chen FT, Chen YJ. Comparison of Intravitreal Dexamethasone Implant and Ranibizumab in Vitrectomized Eyes with Diabetic Macular Edema. J Ophthalmol 2021;2021:8882539. [PMID: 34540287 DOI: 10.1155/2021/8882539] [Reference Citation Analysis]
6 Tayyab H, Ahmed CN, Sadiq MAA. Efficacy and safety of Suprachoroidal Triamcinolone Acetonide in cases of resistant diabetic Macular Edema. Pak J Med Sci 2020;36:42-7. [PMID: 32063929 DOI: 10.12669/pjms.36.2.1194] [Reference Citation Analysis]
7 Kodjikian L, Baillif S, Creuzot-Garcher C, Delyfer MN, Matonti F, Weber M, Mathis T. Real-World Efficacy and Safety of Fluocinolone Acetonide Implant for Diabetic Macular Edema: A Systematic Review. Pharmaceutics 2021;13:72. [PMID: 33430389 DOI: 10.3390/pharmaceutics13010072] [Reference Citation Analysis]
8 Gao L, Zhou L, Tian C, Li N, Shao W, Peng X, Shi Q. Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis. BMC Ophthalmol 2019;19:8. [PMID: 30621640 DOI: 10.1186/s12886-018-1016-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
9 Laursen SB, Erichsen JH, Holm LM, Kessel L. Prevention of macular edema in patients with diabetes after cataract surgery. Journal of Cataract and Refractive Surgery 2019;45:854-69. [DOI: 10.1016/j.jcrs.2019.04.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Fazel F, Nikpour H, Pourazizi M. Combination of Intravitreal Bevacizumab and Topical Dorzolamide versus Intravitreal Bevacizumab Alone for Diabetic Macular Edema: A Randomized Contralateral Clinical Trial. Biomed Res Int 2020;2020:6794391. [PMID: 32016118 DOI: 10.1155/2020/6794391] [Reference Citation Analysis]
11 Mateos-Olivares M, García-Onrubia L, Valentín-Bravo FJ, González-Sarmiento R, Lopez-Galvez M, Pastor JC, Usategui-Martín R, Pastor-Idoate S. Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema. Cells 2021;10:1683. [PMID: 34359853 DOI: 10.3390/cells10071683] [Reference Citation Analysis]
12 Nicolò M, Ferro Desideri L, Vagge A, Traverso CE. Faricimab: an investigational agent targeting the Tie-2/angiopoietin pathway and VEGF-A for the treatment of retinal diseases. Expert Opin Investig Drugs 2021;30:193-200. [PMID: 33471572 DOI: 10.1080/13543784.2021.1879791] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
13 Sultana J, Giorgianni F, Scondotto G, Ientile V, Cananzi P, Leoni O, Addario SWP, De Sarro G, De Francesco A, Puzo MR, Renoux C, Trifirò G. Association Between Intravitreal Aflibercept and Serious Non-ocular Haemorrhage Compared with Intravitreal Ranibizumab: A Multicentre Observational Cohort Study. Drug Saf 2020;43:943-52. [DOI: 10.1007/s40264-020-00956-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Sharma A, Bellala K, Dongre P, Reddy P. Anti-VEGF versus dexamethasone implant (Ozurdex) for the management of Centre involved Diabetic Macular Edema (CiDME): a randomized study. Int Ophthalmol 2020;40:67-72. [DOI: 10.1007/s10792-019-01151-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Kishore K, Bhat PV, Venkatesh P, Canizela CC. Dexamethasone Intravitreal Implant for the Treatment of Macular Edema and Uveitis: A Comprehensive Narrative Review. OPTH 2022;Volume 16:1019-45. [DOI: 10.2147/opth.s209395] [Reference Citation Analysis]
16 Bhatwadekar AD, Kansara VS, Ciulla TA. Investigational plasma kallikrein inhibitors for the treatment of diabetic macular edema: an expert assessment. Expert Opin Investig Drugs 2020;29:237-44. [PMID: 31985300 DOI: 10.1080/13543784.2020.1723078] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
17 Dong Y, Liu Y, Yu J, Qi S, Liu H. Mapping research trends in diabetic retinopathy from 2010 to 2019: A bibliometric analysis. Medicine (Baltimore) 2021;100:e23981. [PMID: 33545985 DOI: 10.1097/MD.0000000000023981] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Fayzrakhmanov RR. [Ozurdex in the treatment of diabetic macular edema. When to prescribe?]. Vestn Oftalmol 2019;135:121-7. [PMID: 31573567 DOI: 10.17116/oftalma2019135041121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Iovino C, Mastropasqua R, Lupidi M, Bacherini D, Pellegrini M, Bernabei F, Borrelli E, Sacconi R, Carnevali A, D'Aloisio R, Cerquaglia A, Finocchio L, Govetto A, Erba S, Triolo G, Di Zazzo A, Forlini M, Vagge A, Giannaccare G. Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the Literature. Pharmaceutics 2020;12:E703. [PMID: 32722556 DOI: 10.3390/pharmaceutics12080703] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
20 Park YG, Park YH. Quantitative Analysis of Retinal Microvascular Perfusion and Novel Biomarkers of the Treatment Response in Diabetic Macular Edema. J Diabetes Res 2020;2020:2132037. [PMID: 33282960 DOI: 10.1155/2020/2132037] [Reference Citation Analysis]
21 Iovino C, Peiretti E, Giannaccare G, Scorcia V, Carnevali A. Evolving Treatment Paradigm in the Management of Diabetic Macular Edema in the Era of COVID-19. Front Pharmacol 2021;12:670468. [PMID: 33912065 DOI: 10.3389/fphar.2021.670468] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 German Society of Ophthalmology (DOG)., German Retina Society (RG)., Professional Association of Ophthalmologists in Germany (BVA). Statement of the German Ophthalmological Society, the German Retina Society, and the Professional Association of Ophthalmologists in Germany on treatment of diabetic macular edema : Dated August 2019. Ophthalmologe 2021;118:40-67. [PMID: 33033871 DOI: 10.1007/s00347-020-01244-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Chou HD, Wu CH, Chiang WY, Chen NN, Hwang YS, Chen KJ, Lai CH, Wu PC, Chen YH, Yeung L, Shao SC, Lai CC, Wu WC. Optical coherence tomography and imaging biomarkers as outcome predictors in diabetic macular edema treated with dexamethasone implant. Sci Rep 2022;12:3872. [PMID: 35264625 DOI: 10.1038/s41598-022-07604-7] [Reference Citation Analysis]
24 Menezo M, Roca M, Menezo V, Pascual I. Intravitreal dexamethasone implant Ozurdex in the treatment of diabetic macular edema in patients not previously treated with any intravitreal drug: a prospective 12-month follow-up study. Current Medical Research and Opinion 2019;35:2111-6. [DOI: 10.1080/03007995.2019.1652449] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Limon U. Early effect of simultaneous intravitreal dexamethasone and bevacizumab combination treatment in patients with persistent diabetic macular edema. J Fr Ophtalmol 2021;44:849-54. [PMID: 33840497 DOI: 10.1016/j.jfo.2020.08.033] [Reference Citation Analysis]
26 Berisha B, Höflechner L, Wedrich A. Disloziertes Dexamethason-Implantat in der Vorderkammer: ein Fallbericht. Spektrum Augenheilkd 2021;35:83-7. [DOI: 10.1007/s00717-020-00481-3] [Reference Citation Analysis]
27 Shen W, Teo KYC, Wood JPM, Vaze A, Chidlow G, Ao J, Lee SR, Yam MX, Cornish EE, Fraser-Bell S, Casson RJ, Gillies MC. Preclinical and clinical studies of photobiomodulation therapy for macular oedema. Diabetologia 2020;63:1900-15. [PMID: 32661752 DOI: 10.1007/s00125-020-05189-2] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Zhao YJ, Zou YL, Lu Y, Tu MJ, You ZP. Intravitreal dexamethasone implant — a new treatment for idiopathic posterior scleritis: A case report. World J Clin Cases 2021; 9(2): 422-428 [PMID: 33521111 DOI: 10.12998/wjcc.v9.i2.422] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Castro-Navarro V, Cervera-Taulet E, Navarro-Palop C, Monferrer-Adsuara C, Hernández-Bel L, Montero-Hernández J. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema. BMC Ophthalmol 2019;19:15. [PMID: 30634940 DOI: 10.1186/s12886-018-1022-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
30 Eandi CM, De Geronimo D, Giannini D, Polito MS, Tosi GM, Neri G, Le Mer Y, Varano M, Parravano M. Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants. Acta Diabetol 2020;57:867-74. [PMID: 32114643 DOI: 10.1007/s00592-020-01504-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Karti O, Saatci AO. Place of intravitreal dexamethasone implant in the treatment armamentarium of diabetic macular edema. World J Diabetes 2021; 12(8): 1220-1232 [PMID: 34512888 DOI: 10.4239/wjd.v12.i8.1220] [Reference Citation Analysis]
32 Behar-Cohen F. Recent advances in slow and sustained drug release for retina drug delivery. Expert Opin Drug Deliv 2019;16:679-86. [PMID: 31092046 DOI: 10.1080/17425247.2019.1618829] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
33 Navel V, Baker JS, Dutheil F. COVID-19 and macular edema: a necessarily blindness? Graefes Arch Clin Exp Ophthalmol 2020;258:2569-70. [PMID: 32666248 DOI: 10.1007/s00417-020-04838-x] [Reference Citation Analysis]
34 Parravano M, Allegrini D, Carnevali A, Costanzo E, Giannaccare G, Giorno P, Scorcia V, Spedicato GA, Varano M, Romano MR. Effectiveness of a Hydrophilic Curcumin-Based Formulation in Coadjuvating the Therapeutic Effect of Intravitreal Dexamethasone in Subjects With Diabetic Macular Edema. Front Pharmacol 2021;12:726104. [PMID: 35058773 DOI: 10.3389/fphar.2021.726104] [Reference Citation Analysis]
35 Cui BH, Zhou W, Wang WW, Yang H, Dong YL, Liu YY, Yan H. Clinical efficacy of intravitreal corticoid as an adjunctive therapy to anti-VEGF treatment of neovascular age-related macular degeneration: a Meta-analysis. Int J Ophthalmol 2021;14:1092-9. [PMID: 34282396 DOI: 10.18240/ijo.2021.07.19] [Reference Citation Analysis]
36 Hu Z, Yang M, Xie C, Gao H, Fu X, Xie H, Liu Y. Effects of qiming granule for diabetic macular edema: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e17496. [PMID: 31626104 DOI: 10.1097/MD.0000000000017496] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
37 Abdelshafy Tabl A, Tawfik Soliman T, Anany Elsayed M, Abdelshafy Tabl M, Meduri A. A Randomized Trial Comparing Suprachoroidal and Intravitreal Injection of Triamcinolone Acetonide in Refractory Diabetic Macular Edema due to Epiretinal Membrane. Journal of Ophthalmology 2022;2022:1-7. [DOI: 10.1155/2022/7947710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Wei W, Chen Y, Hu B, Zhao M, Han M, Dai H, Uy HS, Chen MY, Wang K, Jiao J, Lou J, Li XY. Multicenter, Prospective, Randomized Study of Dexamethasone Intravitreal Implant in Patients with Center-Involved Diabetic Macular Edema in the Asia-Pacific Region. Clin Ophthalmol 2021;15:4097-108. [PMID: 34675477 DOI: 10.2147/OPTH.S325618] [Reference Citation Analysis]
39 Rittiphairoj T, Mir TA, Li T, Virgili G. Intravitreal steroids for macular edema in diabetes. Cochrane Database Syst Rev 2020;11:CD005656. [PMID: 33206392 DOI: 10.1002/14651858.CD005656.pub3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Podkowinski D, Orlowski-Wimmer E, Zlabinger G, Pollreisz A, Mursch-Edlmayr AS, Mariacher S, Ring M, Bolz M. Aqueous humour cytokine changes during a loading phase of intravitreal ranibizumab or dexamethasone implant in diabetic macular oedema. Acta Ophthalmol 2020;98:e407-15. [PMID: 31736269 DOI: 10.1111/aos.14297] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
41 Barone A, Russo V, Maggiore G, Loiodice MS, Stella A, Bux AV, Iaculli C. Dexamethasone intravitreal implant in patients with cataract and naïve diabetic macular edema. Eur J Ophthalmol 2021;:11206721211004395. [PMID: 33757366 DOI: 10.1177/11206721211004395] [Reference Citation Analysis]
42 Yuan Q, Liu Y, Xu H, Gao Y, Qin L, Gou Y, Tao M, Zhang M. Efficacy and safety of single-dose dexamethasone implantation for patients with persistent diabetic macular edema: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol 2021. [PMID: 34550419 DOI: 10.1007/s00417-021-05369-9] [Reference Citation Analysis]